Stephens initiated coverage on Teladoc with a new price target
$TDOC
Medical/Nursing Services
Health Care
Stephens initiated coverage of Teladoc with a rating of Equal-Weight and set a new price target of $25.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/9/2025 | $8.50 | Equal Weight | Barclays |
| 11/13/2025 | $8.00 | Market Perform | BMO Capital Markets |
| 7/25/2025 | $10.00 | Neutral | Mizuho |
| 11/15/2024 | $14.00 | Buy | Goldman |
| 9/17/2024 | $8.00 → $10.00 | Hold | Jefferies |
| 2/29/2024 | $22.00 | Overweight | Cantor Fitzgerald |
| 2/26/2024 | $17.00 | Market Perform | Leerink Partners |
| 1/17/2024 | $33.00 → $22.00 | Buy → Neutral | DA Davidson |
8-K - Teladoc Health, Inc. (0001477449) (Filer)
S-8 - Teladoc Health, Inc. (0001477449) (Filer)
8-K - Teladoc Health, Inc. (0001477449) (Filer)
Barclays initiated coverage of Teladoc with a rating of Equal Weight and set a new price target of $8.50
BMO Capital Markets initiated coverage of Teladoc with a rating of Market Perform and set a new price target of $8.00
Mizuho initiated coverage of Teladoc with a rating of Neutral and set a new price target of $10.00
NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced the launch of new enhancements to its 24/7 Care service. The new capabilities build on the company's flagship virtual urgent care service which provides access to licensed care providers who assess and treat non-emergency medical needs, 24 hours a day, seven days a week. In the enhanced 24/7 Care service, Teladoc Health's care teams now further address health needs by caring for a broader set of conditions, engaging specialist input when needed, supporting preventive care, connecting patients to additional in-network care and checking prescription benefits in real-ti
NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026, at 3:45 p.m. PT (6:45 p.m. ET). A live audio webcast and replay of the presentation will be available at https://ir.teladochealth.com/news-and-events/events-and-presentations. About Teladoc Health Teladoc Health (NYSE:TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a cata
NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced that Chuck Divita, chief executive officer, will participate in the 37th Annual Piper Sandler Healthcare Conference in New York on Tuesday, December 2, 2025, at 12:30 p.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/. About Teladoc HealthTeladoc Health (NYSE:TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better heal
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
NEW YORK, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2025 ("Third Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2024 ("Third Quarter 2024"). Highlights Third Quarter 2025 revenue of $626.4 million, down 2% year-over-yearThird Quarter 2025 net loss of $49.5 million, or $0.28 per shareThird Quarter 2025 adjusted EBITDA of $69.9 million, down 16% year-over-yearIntegrated Care segment revenue of $389.5 million, up 2% year-over-year, and adjusted EBITDA margin of 17.0%BetterHelp seg
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial Officer to pursue an opportunity outside of the healthcare industry. Ms. Murthy will continue to serve in her role until her departure on November 21, 2025 and will present on the company's third quarter earnings conference call. The company has initiated a search process to identify its next CFO. To ensure a seamless transition while the search is completed, an interim leadership structure will be in place with key finance leaders reporting to Teladoc Health Chief Executive Officer Chuck Divita.
NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release third quarter 2025 results on Wednesday, October 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 609817. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=90432. A live audio webcast will also be available online at ht
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- MarketNewsUpdates News Commentary A recent report from ResearchAndMarkets said that the U.S. augmented reality and virtual reality in healthcare market size which was estimated at USD 1.03 billion in 2024 is projected to grow at a CAGR of 15.4% from 2025 to 2030. It said that advancements in healthcare IT infrastructure and increased venture capital investment, fueled by numerous start-ups and government programs such as NIH and FDA initiatives, support AR/VR research. In addition, the declining cost of head-mounted devices, rising demand from telemedicine, chronic disease care, and minimally invasive surgery, and integration with AI and 5G tech
Jason Gorevic to depart the company, effective immediatelyCFO Mala Murthy appointed acting chief executiveTeladoc Health reaffirms guidance PURCHASE, NY, April 05, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that Jason Gorevic is departing the company, effective immediately. The Board of Directors has appointed Mala Murthy acting Chief Executive Officer while it searches for Mr. Gorevic's permanent successor. Ms. Murthy is a seasoned industry leader who has served as the Company's Chief Financial Officer since 2019, and she will continue serving in this role during this transition period. The Board has ret
PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,
SC 13G - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)